however, this test for acute toxicity is relatively insensitive, and criticism has been expressed against these crude animal tests.
Several immunoassays have been developed for the analysis of microcystins. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Unfortunately, none of them have gained widespread application, which may be caused by insufficient sensitivity, unfavorable cross-reactivities and difficult availability. Most desirable would be an immunoassay of broad reactivity towards all microcystins, 6 allowing a measurement of the sum concentration of these compounds, which would be a useful index for regulatory purposes. A known monoclonal antibody 9 against microcystin-LR (MC-LR) was used in this study. The antibody (clone M8H5) had been generated by immunization with a BSA-microcystin-LR conjugate, prepared by coupling the carboxylic groups of microcystin-LR to the protein with a water-soluble carbodiimide (conjugation density MC-LR/BSA 1.3 mol/mol).
Because MC-LR has two carboxylic groups available for conjugation (see Fig. 1 ), the immunogen is not structurally unambiguous.
Most characteristics of M8H5 support the notion that the effective conjugation site was at amino acid (3) , not at (6) . If (6) would have been the conjugation site, one should expect a larger influence of the arginine at position (4) . In addition, the loss of a methyl group at (3) seems to be of minor importance. Other clones isolated in parallel to M8H5 showed relatively similar cross-reactivity patterns. 9 Although the antibody M8H5 showed high affinity to the antigen (k = 1.3 × 10 10 L/mol), the crossreactivity pattern of M8H5 was not broad enough in the previously tested assay formats. The generation of new antibodies 17 may solve such selectivity problems. As shown in many papers, the selectivity of antibodies can be considerably influenced by the orientation of the hapten during immunization. If broad reactivity is desired, the common substructure must be placed at the "outer" side, which is located opposite to the conjugation site to the protein carrier. This approach probably works better with large antigens/haptens, with extended common epitopes. In other cases, all parts of the analyte influence the binding by the antibody, and consequently the cross-reactivity pattern is uneven. However, it should be kept in mind that the production of monoclonal antibodies of high affinity and predetermined selectivity has remained a significant challenge; the efforts and costs involved can be considerable.
There are more economic and feasible ways to modulate the cross-reactivity of an immunoassay. A chemical derivatization of the analytes could be performed, leading to a common product. This was shown for polychlorinated biphenyls (PCBs), which can be catalytically converted into a sole product, biphenyl. 25 Unfortunately, this approach is only suitable for some compound classes. The addition of surfactants 18 or solvents 19 and the variation of pH 20, 21 can be beneficial. Furthermore, the change in the pre-incubation time and/or the tracer incubation time can have an influence on the crossreactivity pattern. 22 Cross-reactivities, defined as the ratio of the midpoints of the calibration curves of a standard and a crossreactant, are closely linked to the affinity constant of an antibody/antigen pair. However, the use of binding kinetics might be a way to escape the dictate of the equilibrium constant, 23 because the affinity constant (equilibrium constant) is dependent on the kinetic association and the kinetic dissociation constant. In addition, it is often claimed that the use of a different competitor (hapten in tracer or coating conjugate) in a competitive immunoassay may influence the cross-reactivity. 24 However, this can not be expected with monoclonal antibodies. An alteration of the assay system itself, e.g., between competitive and non-competitive, or antibodyimmobilized and antigen-immobilized systems, might also be effective.
In this study, we used the antibody M8H5 in a direct competitive enzyme immunoassay performed in microtitration plates, and found a significantly broadened specificity.
Experimental

Reagents and chemicals
Microcystins were obtained by Alexis Deutschland GmbH (Grünberg, Germany), Calbiochem Corp. (San Diego, USA) and AnagnosTec GmbH (Luckenwalde, Germany). The monoclonal antibody M8H5 was produced with an MC-LR-BSA immunogen in BALB/c mice, as previously described, 9 and could be obtained by one of the authors (S.N.). Adda ((2S,3S,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-(4E,6E)-dienoic acid) was kindly provided by Dr. D. Cundy and Dr. T. McCarthy (CSIRO Molecular Science, Clayton South, Victoria, Australia). The enzyme tracer was prepared as described in a recent publication. 26 Briefly, microcystin-LR was conjugated to peroxidase, which had been treated with Traut's reagent 27 (2-iminothiolane hydrochloride) to introduce thiol groups, which are suitable for an addition to the double bond of dehydroalanine in microcystin-LR at high pH. Humic acid (sodium salt) was purchased from Roth (Karlsruhe, Germany). All other chemicals were obtained from Sigma-Aldrich (Steinheim, Germany) or Merck (Darmstadt, Germany). Safety information: Microcystins and nodularins are extremely toxic compounds and have to be handled with extraordinary care.
Procedure
96-well microtiter plates were coated with 250 µL anti-mouse IgG (Fc-specific) serum from goat (ICN Pharmaceuticals) in a dilution of 1:3000 (coating buffer, 40 mM carbonate, pH 9.6) while shaking overnight at room temperature (RT). After a first washing step with phosphate buffered saline (PBS, pH 7.6, plus 0.05% Tween 20), the wells were incubated with the monoclonal antibody M8H5 (200 µL, about 20 µg/L) in PBS for 3 h at RT. After a further washing step, the microcystin standards and samples (200 µL per well) were added to the plate. The standard solutions were prepared in purified water from a stock solution in methanol (about 1 g/L). The stock solutions were calibrated at the UV absorbance (238 nm) in relation to a known concentration of microcystin-LR or using the extinction coefficient of microcystin-LR of ε = 39800 L/(mol cm). 28, 29 After a preincubation of 30 min, the peroxidase tracer was added (50 µL, 0.64 mg/L) for an additional 30 min. Then, the microtiter plate was washed and a substrate solution (tetramethylbenzidine, hydrogen peroxide, citrate buffer, pH 3.8) was added (200 µL per well). After a suitable development time (up to 30 min) the reaction was stopped with diluted sulfuric acid (5%, 100 µL). Subsequently, the plates were measured at 450 nm (reference wavelength: 620 nm) with a microplate reader. The 4-parameter logistic function has been used for fitting the calibration curves, 23 which consisted of at least 8 different concentrations (including blank) measured in triplicate. The error of the CRs was calculated according to the law of propagation of errors from the standard deviations of the involved midpoints.
Results and Discussion
Cross-reactivities
In Table 1 the cross-reactivities of microcystins, nodularin and Adda in different immunoassay formats are shown. They vary between 100 and 156% for all microcystins and nodularin. In contrast to the indirect immunoassay (immobilized antigen), where for instance microcystin-LA showed a cross-reactivity (CR) of only 26%, which caused some debate on a possible underestimation of microcystin contaminations, in the direct assay there is no significant difference in relation to MC-LR (100%). The same applies to all other tested microcystins; even nodularin is not discriminated. However, the non-toxic amino acid Adda showed only a very low CR. Hence, it can be suspected that some constant regions in microcystins (and nodularin) are important for the binding of the antibody M8H5.
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ANALYTICAL SCIENCES DECEMBER 2001, VOL. 17 (2) and (4) The variation of the amino acid at position 4 (arginine in MC-LR) does not show any significant influence. This is in sharp contrast to an antibody (clone MC10E7), which was described recently. 26 The iso-glutamic acid may be of some importance, since it belongs to the constant region of microcystins and nodularins. In addition, it is likely that the cyclic structure facilitates the binding, because microcystins and nodularins are quite rigid molecules. 30 Unfortunately, there is no clear rationale for the broad specificity (Fig. 2) in the presented assay format in contrast to the assays published previously. One could speculate that the incubation times of the assays have some influence on the selectivity. In Table 1 it is shown that the assay presented in this paper has a total incubation time of only 1 h, whereas other assays used incubation times of at least 12 h. Therefore, we assume that kinetic effects may be responsible for this difference. In numerical simulations (data not shown) we found that the influence of the incubation times is relatively complex and depends very much on the kinetic constants and conditions of the test. Because most of the required parameters are not known in real assays, the usefulness of such calculations is still limited. Nevertheless, from theory one can expect a significant influence of the incubation time of the analyte as well as the incubation time of the tracer on the cross-reactivities.
Sensitivity
Considering the guideline level for drinking water of 1 µg/L for MC-LR proposed by the World Health Organization (WHO), the sensitivity of the immunoassay is more than sufficient. In Fig. 3 , a typical calibration curve is shown. The midpoint (IC50) of 0.22 µg/L and the detection limit around 50 ng/L (3s definition) are well below the WHO level mentioned above. Furthermore, the short incubation steps make it possible to perform a direct immunoassay in less than 2 h. An even much shorter assay duration might be achievable. 22 
Stability tests
Proteins, such as antibodies, are relatively susceptible to matrix effects and harsh conditions. Nevertheless, some antibodies are much more robust than others. Although quite a few research projects have been conducted to examine protein stability and to design improved proteins, in practice, most biochemical reagents are used in their native form and stability issues are treated in a largely empirical way. In environmental analysis, the variation of the matrix may be considerable and was always a point of concern. We routinely perform special stability tests with antibodies used for analytical purposes.
Humic acids (and fulvic acids) often cause interferences in environmental samples, since they may interact strongly with biochemical reagents. 31 Some experiments suggest that there is a correlation between the robustness of antibodies in real-life assays and their stability against humic acids. One method to quantify the effect of a matrix compound is to measure its "cross-reactivity" similar to a true cross-reactant. The main difference of these assays to standard cross-reactivity studies is the used concentration range. Matrix compounds are tested in much higher concentrations, sometimes up to 100%. At least two different experimental setups for direct competitive assays are possible. 26 The first is identical to the intended immunoassay procedure, but instead of samples, solutions with matrix compounds are used. The second setup is to introduce an additional washing step before the enzyme tracer is added. This latter test mainly explores the stability of the antibody, not of the test as a whole. This kind of test is better for antibody characterization, as otherwise the differences might be hidden behind the instabilities of other reagents. On the other hand, it should not be concluded that the conditions, which do not harm the antibody, are necessarily suitable for the complete immunoassay procedure. Often the enzyme tracer was the critical reagent and not the antibody.
In Table 2 some robustness tests are summarized. The tests have been performed similar to the assay described under Procedure.
However, instead of samples, the indicated solutions have been used. The tests have been performed with an intermediate washing step between analyte and tracer incubation to avoid any contact of the test solution with the enzyme. An inhibition of less than 10% was defined to be acceptable. In addition, we recommend the use of a blocking solution, prior to the addition of the samples, which "neutralizes" many nonspecific effects of the sample. 32 The blocking solution may consist of a Tris-buffer (pH 7.5), sodium chloride, EDTA and bovine serum albumin (BSA). This minimizes the negative effects of humic acids as they are bound by the protein. 31 In addition, harmful metal ions should be complexed. The buffer avoids pH-shifts, which are known to influence immunoassays considerably.
The addition of tetramethylbenzidine (0.01 mM) to the peroxidase tracer solution has been proven to be of advantage because the oxidative damage of the enzyme is suppressed. 33 The stability of the microcystin-peroxidase conjugate (enzyme tracer) has been discussed recently. 26 The robust nature of this antibody should make the proposed test suitable for the measurement of 1447 ANALYTICAL SCIENCES DECEMBER 2001, VOL. 17 real samples, not only of drinking water, but also of surface water, of which the matrix may be much more difficult. Even the high-throughput screening of many samples in a short time seems to be possible with this fast and sensitive assay.
Conclusion
This direct competitive enzyme immunoassay based on the monoclonal antibody M8H5 shows a very even cross-reactivity pattern for microcystins and nodularin. It can be concluded that none of the cross-reactivities (except the non-toxic amino acid Adda) is significantly different from 100%. Hence, the assay is well suited to determine the sum concentration of microcystins in water samples. Because microcystins have quite similar molecular masses, the mass-related sum value is essentially equivalent to the molar sum value. Although this is not an equivalent of toxicity, the sum of microcystin concentration may be useful for regulatory purposes, because for many of the microcystins reliable toxicity data are not available. It is very likely that even unknown microcystin variants can be detected by this assay. The detection limit of around 0.05 µg/L is low enough to enable the testing for violations of the proposed WHO level of 1 µg/L for microcystin-LR in drinking water. It may suffice that the assay is calibrated with MC-LR, which is commercially available. Finally, it could be shown that M8H5 is quite robust against matrix effects, and therefore should not be prone to false positive values, false negative values are usually very rare in competitive immunoassays. The sensitivity and robustness of the antibody was already demonstrated in several studies, in which real samples from Japan, Thailand, China, Germany and Portugal have been examined. 10, 11, 16, 34 
